Jacqueline A French

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi request reprint Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
    Jacqueline A French
    Neurological Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 45:410-23. 2004
  2. ncbi request reprint Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
    Jacqueline A French
    Neurological Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 45:401-9. 2004
  3. ncbi request reprint Likelihood of seizure remission in an adult population with refractory epilepsy
    Brian C Callaghan
    Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA
    Ann Neurol 62:382-9. 2007
  4. ncbi request reprint Levetiracetam safety profiles and tolerability in epilepsy patients
    Deborah E Briggs
    Department of Neurology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104 4283, USA
    Expert Opin Drug Saf 3:415-24. 2004
  5. ncbi request reprint Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures
    Daniel Friedman
    Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104 4283, USA
    Neurology 66:590-1. 2006
  6. ncbi request reprint Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs
    Deana M Gazzola
    Hospital of the University of Pennsylvania, Department of Neurology, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 48:1303-7. 2007
  7. ncbi request reprint First-choice drug for newly diagnosed epilepsy
    Jacqueline A French
    Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA
    Lancet 369:970-1. 2007
  8. ncbi request reprint Guidelines for new antiepileptic drug evaluation
    John D Hixson
    Department of Neurology, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
    Rev Neurol Dis 1:S18-26. 2004
  9. ncbi request reprint Can evidence-based guidelines and clinical trials tell us how to treat patients?
    Jacqueline A French
    Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 48:1264-7. 2007
  10. ncbi request reprint Refractory epilepsy: clinical overview
    Jacqueline A French
    Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Epilepsia 48:3-7. 2007

Detail Information

Publications28

  1. ncbi request reprint Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
    Jacqueline A French
    Neurological Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 45:410-23. 2004
    ....
  2. ncbi request reprint Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
    Jacqueline A French
    Neurological Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 45:401-9. 2004
    ..S. Food and Drug Administration] in the treatment of children and adults with newly diagnosed partial and generalized epilepsies...
  3. ncbi request reprint Likelihood of seizure remission in an adult population with refractory epilepsy
    Brian C Callaghan
    Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA
    Ann Neurol 62:382-9. 2007
    ..We aimed to determine the likelihood of remission and its clinical predictors in adult patients meeting a strict definition of refractory epilepsy. We also wanted to investigate the influence of treatment regimen on remission...
  4. ncbi request reprint Levetiracetam safety profiles and tolerability in epilepsy patients
    Deborah E Briggs
    Department of Neurology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104 4283, USA
    Expert Opin Drug Saf 3:415-24. 2004
    ..Adjustments in dosing are required for decreases in renal clearance...
  5. ncbi request reprint Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures
    Daniel Friedman
    Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104 4283, USA
    Neurology 66:590-1. 2006
    ..These results suggest a useful treatment strategy for patients with refractory epilepsy who have developed resistance to AEDs...
  6. ncbi request reprint Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs
    Deana M Gazzola
    Hospital of the University of Pennsylvania, Department of Neurology, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 48:1303-7. 2007
    ..The goal of this study is to (1) provide clinically useful, previously unpublished comparative analyses of seizure-freedom rates for newer antiepileptic drugs (AEDs), and (2) recommend a standard for data presentation and analysis...
  7. ncbi request reprint First-choice drug for newly diagnosed epilepsy
    Jacqueline A French
    Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA
    Lancet 369:970-1. 2007
  8. ncbi request reprint Guidelines for new antiepileptic drug evaluation
    John D Hixson
    Department of Neurology, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
    Rev Neurol Dis 1:S18-26. 2004
    ..Neurologists are encouraged to integrate the AAN guidelines with clinical experience, opinion, and other considerations of special populations until an exhaustive set of guidelines is available for a wide variety of seizure types...
  9. ncbi request reprint Can evidence-based guidelines and clinical trials tell us how to treat patients?
    Jacqueline A French
    Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 48:1264-7. 2007
  10. ncbi request reprint Refractory epilepsy: clinical overview
    Jacqueline A French
    Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Epilepsia 48:3-7. 2007
    ....
  11. ncbi request reprint October 2002: 27-year-old female with epilepsy
    Zissimos Mourelatos
    Division of Neuropathology, Department of Pathology, University of Pennsylvania Medical Center, Philadelphia, USA
    Brain Pathol 13:233-4, 239. 2003
    ..The treatment of choice is functionally complete hemispherectomy with complete disconnection of the frontal and occipital lobes...
  12. ncbi request reprint Neurosyphilis and status epilepticus: case report and literature review
    Beau M Ances
    Department of Neurology, University of Pennsylvania Medical Center, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Epilepsy Res 59:67-70. 2004
    ..Neurosyphilis should be considered in the differential diagnosis of patients presenting with status epilepticus...
  13. ncbi request reprint A workshop on antiepileptic drug monotherapy indications
    Jacqueline A French
    The Neurological Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 43:3-27. 2002
  14. ncbi request reprint Active control trials for epilepsy: avoiding bias in head-to-head trials
    Jacqueline A French
    Neurology 66:1294-5. 2006
  15. ncbi request reprint Guidelines--are they useful?
    Elinor Ben-Menachem
    Department of Clinical Neuroscience, Sahlgrenska Academy, Goteborg University, Goteborg, Sweden
    Epilepsia 47:62-4. 2006
    ..Although guidelines may not answer all questions it is critical that clinicians using them consider the available evidence, as well as the quality of the evidence, when incorporating the information in their decision making...
  16. ncbi request reprint Antiepileptic drugs for the elderly: using the old to focus on the new
    Jacqueline A French
    Neurology 64:1834-5. 2005
  17. ncbi request reprint Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy
    Christian Otoul
    UCB Pharma, Braine l Alleud, Belgium
    Clin Neuropharmacol 28:72-8. 2005
    ..These meta-analyses give only short-term efficacy and safety data. Comparative clinical trials and long-term studies of these agents are needed to confirm these findings...
  18. ncbi request reprint A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events
    Andres M Kanner
    Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Rush Medical College, 1653 West Congress Parkway, Chicago, IL 60612, USA
    Epilepsy Behav 4:548-52. 2003
    ....
  19. ncbi request reprint Role of levetiracetam in the treatment of epilepsy
    Martin J Brodie
    Epilepsy Unit, Division of Cardiovascular and Medical Sciences, Western Infirmary, Glasgow, Scotland, United Kingdom
    Epileptic Disord 5:S65-72. 2003
    ..Levetiracetam has specific characteristics that make it an optimal choice for many patient populations...
  20. ncbi request reprint Postmarketing surveillance of new antiepileptic drugs: the tribulations of trials
    Jacqueline A French
    Epilepsia 43:951-5. 2002
  21. ncbi request reprint Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled study
    Dorothée G A Kasteleijn Nolst Trenité
    University La Sapienza II, Via Vitorchiano 81, 00189 Roma, Italy
    Epilepsy Res 74:193-200. 2007
    ....
  22. ncbi request reprint Is refractory epilepsy preventable?
    Santiago Arroyo
    Epilepsy Unit, Hospital Clinic i Provincial, Barcelona, Spain
    Epilepsia 43:437-44. 2002
    ..The early initiation of aggressive therapy may improve outcome and overall quality of life...
  23. ncbi request reprint New antiepileptic drugs--discovery, development, and update
    Roger J Porter
    Neurotherapeutics 4:2-3. 2007
  24. ncbi request reprint Fear sensitivity and the psychological profile of patients with psychogenic nonepileptic seizures
    John D Hixson
    Department of Neurology, University of California, San Francisco, CA 94143 0114, USA
    Epilepsy Behav 9:587-92. 2006
    ..This finding may reflect an elevated internal "setpoint" for appraising the intensity of emotional settings...
  25. ncbi request reprint How trial designs impact on guidelines
    Jacqueline A French
    Epilepsy Res 68:56-60. 2006
    ..Understanding of the variables that will be considered for treatment guidelines can improve the methodological strength of studies and lead to recommendations for practice...
  26. ncbi request reprint VNS Therapy versus the latest antiepileptic drug
    Elinor Ben-Menachem
    Department of Clinical Neuroscience, Sahlgren University Hospital, Sweden
    Epileptic Disord 7:S22-6. 2005
    ....
  27. ncbi request reprint Electrical stimulation of the anterior nucleus of the thalamus for the treatment of intractable epilepsy
    John F Kerrigan
    Department of Neurology, Barrow Neurological Institute, St Joseph s Hospital and Medical Center, Phoenix, Arizona, USA
    Epilepsia 45:346-54. 2004
    ....
  28. doi request reprint Clinical practice. Initial management of epilepsy
    Jacqueline A French
    Department of Neurology, New York University School of Medicine, New York, USA
    N Engl J Med 359:166-76. 2008